COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,633 Articles (22,913 medRxiv, 8,720 bioRxiv)

Most recent first Previous |  Page 663: Articles 6621-6630  | Next

Commercial immunoglobulin products now contain neutralising antibodies against SARS-CoV-2 spike antibody which are detectable in patient serum
Upasani, V., O'Sullivan, M., Moreira, F., Workman, S., Symes, A., Burns, S. O., Tadros, S., McCoy, L. E., Lowe, D. M.
10.1101/2022.09.22.22280216 — Posted: 2022-09-23
Fully Quantitative Measurements of Differential Antibody Binding to Spike Proteins from Wuhan, Alpha, Beta, Gamma, Delta and Omicron BA.1 variants of SARS-CoV-2: Antibody Immunity Endotypes
James-Pemberton, P. H., Kohli, S., Twynham, J., Westlake, A., Antil, A., Hunt, J., Olkhov, R., Shaw, A.
10.1101/2022.09.23.22280271 — Posted: 2022-09-23
Wastewater surveillance of human influenza, metapneumovirus, parainfluenza, respiratory syncytial virus (RSV), rhinovirus, and seasonal coronaviruses during the COVID-19 pandemic
Boehm, A., Hughes, B., Duong, D., Chan-Herur, V., Buchman, A., Wolfe, M. K., White, B.
10.1101/2022.09.22.22280218 — Posted: 2022-09-23
Efficacy and safety of convalescent plasma versus standard care in hospitalized patients with COVID-19 from the Peruvian Social Security Health System: open-label, randomized, controlled clinical trial
Villanueva, C., Neyra, I., Sagastegui, A., Chunga, A., Oyanguren, M., Guillermo-Roman, M., Soto-Ordonez, S., Maguina, J. L., Hurtado-Roca, Y., Soto-Becerra, P., Araujo-Castillo, R. V.
10.1101/2022.09.21.22280195 — Posted: 2022-09-23
Infliximab for Treatment of Adults Hospitalized with Moderate or Severe Covid-19
O'Halloran, J., Kedar, E., Anstrom, K. J., McCarthy, M. W., Ko, E. R., Segura Nunez, P., Boucher, C., Smith, P. B., Panettieri, R. A., Mendivil Tuchia de Tai, S., Maillo, M., Khan, A., Mena Lora, A. J., Salathe, M., Capo, G., Rodriguez Gonzalez, D., Patterson, T. F., Palma, C., Ariza, H., Patelli Lima, M., Lachiewicz, A. M., Blamoun, J., Nannini, E., Sprinz, E., Mykietiuk, A., Alicic, R., Rauseo, A. M., Wolfe, C. R., Wittig, B., Benjamin, D. K., McNulty, S. E., Zakroysky, P., Halabi, S., Butler, S., Atkinson, J., Adam, S. J., Melsheimer, R., Chang, S., LaVange, L., Proschan, M., Bozzette, S. A., Powderly, W. G.
10.1101/2022.09.22.22280245 — Posted: 2022-09-23
Post-COVID-19 syndrome: retinal microcirculation as a potential marker for chronic fatigue
Schlick, S., Lucio, M., Bartsch, A. J., Skornia, A., Hoffmanns, J., Szewczykowski, C., Schroeder, T., Raith, F., Rogge, L., Heltmann, F., Moritz, M., Beitlich, L., Schottenhamml, J., Herrmann, M., Harrer, T., Ganslmayer, M., Kruse, F. E., Laemmer, R., Mardin, C., Hohberger, B.
10.1101/2022.09.23.22280264 — Posted: 2022-09-23
Less invasive SARS-CoV-2 testing for children: A comparison of saliva and a novel Anterior Nasal Swab
Tosif, S., Lee, L.-Y., Nguyen, J., Selman, C., Grobler, A., McMinn, A., Steer, A., Daley, A., Crawford, N.
10.1101/2022.09.21.22280208 — Posted: 2022-09-23
Higher risk of SARS-CoV-2 Omicron BA.4/5 infection than of BA.2 infection after previous BA.1 infection, the Netherlands, 2 May to 24 July 2022
Andeweg, S. P., de Gier, B., Vennema, H., van Walle, I., van Maarseveen, N., Kusters, N. E., de Melker, H. E., Hahne, S. J. M., van den Hof, S., Eggink, D., Knol, M. J.
10.1101/2022.09.21.22280189 — Posted: 2022-09-23
Pharmacological inhibition of bromodomain and extra-terminal proteins induces NRF-2-mediated inhibition of SARS-CoV-2 replication and is subject to viral antagonism
Mhlekude, B., Postmus, D., Weiner, J., Stenzel, S., Zapatero-Belinchon, F. J., Olmer, R., Jansen, J., Richter, A., Heinze, J., Heinemann, N., Muhlemann, B., Schroeder, S., Jones, T. C., Muller, M. A., Drosten, C., Pich, A., Thiel, V., Martin, U., Niemeyer, D., Gerold, G., Beule, D., Goffinet, C.
10.1101/2022.09.22.508962 — Posted: 2022-09-23
Generation and functional analysis of defective viral genomes during SARS-CoV-2 infection
Zhou, T., Gilliam, N. J., Li, S., Spaudau, S., Osborn, R., Anderson, C. S., Mariani, T. J., Thakar, J., Dewhurst, S., Mathews, D. H., Huang, L., Sun, Y.
10.1101/2022.09.22.509123 — Posted: 2022-09-23

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).